» Articles » PMID: 38286876

Evidence and Therapeutic Implications of Biomechanically Regulated Immunosurveillance in Cancer and Other Diseases

Overview
Journal Nat Nanotechnol
Specialty Biotechnology
Date 2024 Jan 29
PMID 38286876
Authors
Affiliations
Soon will be listed here.
Abstract

Disease progression is usually accompanied by changes in the biochemical composition of cells and tissues and their biophysical properties. For instance, hallmarks of cancer include the stiffening of tissues caused by extracellular matrix remodelling and the softening of individual cancer cells. In this context, accumulating evidence has shown that immune cells sense and respond to mechanical signals from the environment. However, the mechanisms regulating these mechanical aspects of immune surveillance remain partially understood. The growing appreciation for the 'mechano-immunology' field has urged researchers to investigate how immune cells sense and respond to mechanical cues in various disease settings, paving the way for the development of novel engineering strategies that aim at mechanically modulating and potentiating immune cells for enhanced immunotherapies. Recent pioneer developments in this direction have laid the foundations for leveraging 'mechanical immunoengineering' strategies to treat various diseases. This Review first outlines the mechanical changes occurring during pathological progression in several diseases, including cancer, fibrosis and infection. We next highlight the mechanosensitive nature of immune cells and how mechanical forces govern the immune responses in different diseases. Finally, we discuss how targeting the biomechanical features of the disease milieu and immune cells is a promising strategy for manipulating therapeutic outcomes.

Citing Articles

ITGB1/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1α degradation.

Li X, Zhao H, Jiang E, Liu P, Chen Y, Wang Y Oncogene. 2025; .

PMID: 40044983 DOI: 10.1038/s41388-025-03317-z.


Microfluidic technologies for enhancing the potency, predictability and affordability of adoptive cell therapies.

Wang Z, Kelley S Nat Biomed Eng. 2025; .

PMID: 39953325 DOI: 10.1038/s41551-024-01315-2.


Probing the physical hallmarks of cancer.

Nia H, Munn L, Jain R Nat Methods. 2025; .

PMID: 39815103 DOI: 10.1038/s41592-024-02564-4.


Increased perfluorooctanoic acid accumulation facilitates the migration and invasion of lung cancer cells via remodeling cell mechanics.

Mei J, Jiang J, Li Z, Pan Y, Xu K, Gao X Proc Natl Acad Sci U S A. 2024; 121(51):e2408575121.

PMID: 39665760 PMC: 11665856. DOI: 10.1073/pnas.2408575121.


Microfluidic Nanoparticle Separation for Precision Medicine.

Lan Z, Chen R, Zou D, Zhao C Adv Sci (Weinh). 2024; 12(4):e2411278.

PMID: 39632600 PMC: 11775552. DOI: 10.1002/advs.202411278.


References
1.
Klotter V, Gunchick C, Siemers E, Rath T, Hudel H, Naehrlich L . Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study. PLoS One. 2017; 12(6):e0178784. PMC: 5456384. DOI: 10.1371/journal.pone.0178784. View

2.
Medrano L, Garcia-Broncano P, Berenguer J, Gonzalez-Garcia J, Jimenez-Sousa M, Guardiola J . Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients. AIDS. 2018; 32(9):1095-1105. DOI: 10.1097/QAD.0000000000001787. View

3.
Tomlin H, Piccinini A . A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens. Immunology. 2018; 155(2):186-201. PMC: 6142291. DOI: 10.1111/imm.12972. View

4.
Martinez-Vidal L, Murdica V, Venegoni C, Pederzoli F, Bandini M, Necchi A . Causal contributors to tissue stiffness and clinical relevance in urology. Commun Biol. 2021; 4(1):1011. PMC: 8390675. DOI: 10.1038/s42003-021-02539-7. View

5.
Mohammadi H, Sahai E . Mechanisms and impact of altered tumour mechanics. Nat Cell Biol. 2018; 20(7):766-774. DOI: 10.1038/s41556-018-0131-2. View